Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Connie Rhee

Nephrology Santa Monica, CA Medical Doctor

NPI 1083835276 CMS profile 48883

1245 16Th St Ste 307, Santa Monica, CA 90404

Open in the dashboard

General payments

$95,684

100 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$121,897 paid to institutions, not to them · program years 2020–2023

Through program year 2025, Connie Rhee of Santa Monica, CA is reported in the CMS Open Payments database as having received $95,684 across 100 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $121,897 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Nephrology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,885 4
2024 General $5,222 3
2023 General $16,997 11
2022 General $30,908 34
2021 General $14,951 11
2020 General $11,020 9
2019 General $12,702 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Connie Rhee
  • Nephrology median
  • Middle half of Nephrology
  • National median

In program year 2025, general payments to Connie Rhee were reported at $3,885. Among 8,186 Nephrology profiles paid that year, the median was $310 and the middle half received between $104 and $880.

Show as a table
Year Connie Rhee Nephrology median Middle half National median
2019 $12,702 $236 $90–$588 $163
2020 $11,020 $135 $46–$364 $114
2021 $14,951 $202 $67–$551 $132
2022 $30,908 $242 $77–$695 $149
2023 $16,997 $254 $84–$766 $160
2024 $5,222 $300 $99–$852 $164
2025 $3,885 $310 $104–$880 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AstraZeneca Pharmaceuticals LP $51,262 60 payments
  2. Fresenius USA Marketing, Inc. $23,277 26 payments
  3. AstraZeneca UK Limited $9,647 5 payments
  4. Relypsa, Inc. $4,559 4 payments
  5. Dexcom, Inc. $3,808 3 payments
  6. Scpharmaceuticals Inc. $3,132 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $69,852 37 payments
  2. Honoraria $10,775 5 payments
  3. Travel and Lodging $8,870 19 payments
  4. Food and Beverage $3,267 34 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $2,499 2 payments
  6. Education $322 2 payments
  7. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $100 1 payment
Products named General payments · program years 2019–2025
  1. LOKELMA $32,339 41 payments
  2. Velphoro $19,421 22 payments
  3. FARXIGA $14,724 11 payments
  4. FUROSCIX $3,132 2 payments
  5. DEXCOM G7 GSS (161) $2,023 2 payments
  6. Veltassa Hyperkalemia $108 1 payment
  7. Veltassa Nephrology $59 1 payment
  8. KORSUVA $30 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

100 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nephrology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record